Park Place Capital’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-40
Closed -$1.33K – 513
2026
Q1
$1.33K Hold
40
– – ﹤0.01% 789
2025
Q4
$1.38K Hold
40
– – ﹤0.01% 751
2025
Q3
$1.09K Hold
40
– – ﹤0.01% 752
2025
Q2
$845 Hold
40
– – ﹤0.01% 783
2025
Q1
$655 Buy
+40
New +$852 ﹤0.01% 801
2024
Q4
– Sell
-25
Closed -$792 – 842
2024
Q3
$792 Hold
25
– – ﹤0.01% 837
2024
Q2
$878 Hold
25
– – ﹤0.01% 835
2024
Q1
$1.1K Buy
+25
New +$1.08K ﹤0.01% 876

Other funds holding IDYA

Park Place Capital's IDYA Position: Q2 2026 in Review

Park Place Capital sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 40 shares — an estimated $1.33K sold.

Park Place Capital first reported a position in IDYA in Q1 2024 and held it in 8 quarters. The position peaked at $1.38K in Q4 2025. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Park Place Capital reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
  • Park Place Capital sold 40 IDEAYA Biosciences shares in Q2 2026, an estimated $1.33K.
  • Park Place Capital first reported a position in IDEAYA Biosciences in Q1 2024 and held it in 8 quarters.
  • Park Place Capital's IDEAYA Biosciences position peaked at $1.38K in Q4 2025.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.